Výsledky vyhledávání

Improvement in Exercise Tolerance and Symptoms of Congestive Heart Failure During Treatment With Candesartan Cilexetil

Autor: R. Spacek, J. Münz, V. von Behren, H. Pethig, Guenter Riegger, H.-J. Arens, H. Bouzo, M. George, P. Petr

Publikováno v: Circulation. 100:2224-2230

Background —The renin-angiotensin system plays an important part in the pathogenesis of congestive heart failure (CHF). This study evaluated the effect of an angiotensin II type 1 receptor antagonist on exercise tolerance and symptoms of CHF. Metho

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2f4de87f2e99d9ac75052d1f5a3ee618
https://doi.org/10.1161/01.cir.100.22.2224

Zobrazit plný text záznamu

Improvement in exercise tolerance and symptoms of congestive heart failure during treatment with candesartan cilexetil. Symptom, Tolerability, Response to Exercise Trial of Candesartan Cilexetil in Heart Failure (STRETCH) Investigators

Autor: G A, Riegger, H, Bouzo, P, Petr, J, Münz, R, Spacek, H, Pethig, V, von Behren, M, George, H, Arens

Publikováno v: Circulation. 100(22)

The renin-angiotensin system plays an important part in the pathogenesis of congestive heart failure (CHF). This study evaluated the effect of an angiotensin II type 1 receptor antagonist on exercise tolerance and symptoms of CHF.In this multicenter,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c5362a540d61003d876e4caf5ba3d36e
https://pubmed.ncbi.nlm.nih.gov/11120711

Zobrazit plný text záznamu

Effect of cisapride on relapse of esophagitis. A multinational, placebo-controlled trial in patients healed with an antisecretory drug. The Italian Eurocis Trialists

Autor: A L, Blum, B, Adami, M H, Bouzo, G, Brandstätter, I, Fumagalli, J P, Galmiche, H, Hebbeln, E, Hentschel, W, Hüttemann, E, SChütz

Publikováno v: Digestive diseases and sciences. 38(3)

The effect of a prokinetic agent, cisapride, on the relapse of reflux esophagitis was investigated in a randomized, double-blind trial conducted in 443 patients whose esophagitis had previously been healed with an acid antisecretory drug. Patients re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::925889d3220d09d41a430b6f4a26d547
https://pubmed.ncbi.nlm.nih.gov/8444088

Zobrazit plný text záznamu

Prokinetic drug treatment (cisapride) is as effective as H2-blocking agent (ranitidine) in the treatment of gastric ulcer

Autor: B, Simon, W, Bergemann, H, Bouzo, W, Hüttemann, F, Hotz, P, Müller, W, Rösch

Publikováno v: Hepato-gastroenterology. 38

A double-blind, randomized, parallel-group multicenter study was conducted in 120 patients with gastric ulcer to compare cisapride, 10 mg t.i.d., and ranitidine, 150 mg b.i.d., administered over 8 weeks. No significant differences between the results

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0c87a9da09443c05ec49f85205b1dafb
https://pubmed.ncbi.nlm.nih.gov/1823066

Zobrazit plný text záznamu

Akademický článek

Observation of isoscalar multipole strengths in exotic doubly-magic 56Ni in inelastic α scattering in inverse kinematics

Publikováno v: Physics Letters B, Vol 751, Iss C, Pp 371-375 (2015)

The Isoscalar Giant Monopole Resonance (ISGMR) and the Isoscalar Giant Dipole Resonance (ISGDR) compression modes have been studied in the doubly-magic unstable nucleus 56Ni. They were measured by inelastic α-particle scattering in inverse kinematic

Externí odkaz: https://doaj.org/article/405f835bfd2f47e8be7ca7b494fc7d32

Zobrazit plný text záznamu

Cisapride versus ranitidine in the treatment of reflux esophagitis

Autor: H D, Janisch, W, Hüttemann, M H, Bouzo

Publikováno v: Hepato-gastroenterology. 35(3)

The healing effect of the prokinetic drug cisapride (10 mg q.i.d.) on esophageal lesions, and its therapeutic control of gastroesophageal reflux symptoms were compared with the effects of the H2-antagonist ranitidine (150 mg b.i.d. + placebo b.i.d.)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::48d25f40a20c943ae9b3196a8994191b
https://pubmed.ncbi.nlm.nih.gov/3042576

Zobrazit plný text záznamu

[Ranitidine in the treatment of non-steroidal anti-inflammatory agent-induced damage of the stomach and duodenal mucosa. Results of a randomized, placebo-controlled double-blind study in patients with rheumatic diseases]

Autor: B, Simon, K H, Beckers, W, Biewer, M H, Bouzo, H G, Dammann, H J, Gebest, P, Müller, E, Schütz

Publikováno v: Zeitschrift fur Gastroenterologie. 26(6)

46 patients with rheumatic diseases suffering from dyspepsia and endoscopically proven gastroduodenal lesions entered a double-blind placebo-controlled study with ranitidine 150 mg b.i.d. over 4-8 weeks. The patients had to be treated for at least 3

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::658e95d14de5ccb812e34e670a158bbb
https://pubmed.ncbi.nlm.nih.gov/3061183

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání